Daejeon, South Korea

Chulhee Choi

This inventor holds 9 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Ilias Biologics Inc., Ilias Therapeutics, Inc., Korea Advanced Institute of Science and Technology. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chulhee Choi. Retrieved from https://idiyas.com/inventor/chulhee-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 88.9

 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2012-2026

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Mind of Chulhee Choi: Leading Advances in Exosome Research

Introduction

Chulhee Choi, an accomplished inventor based in Daejeon, South Korea, has made significant strides in the field of biotechnology, particularly through his research on exosomes. With a total of seven patents to his name, Choi has dedicated his career to developing methods for the targeted delivery of active substances vital in treating various diseases.

Latest Patents

Chulhee Choi's recent patents showcase his groundbreaking innovations in exosome application. One notable invention is titled "Exosomes for target specific delivery and methods for preparing and delivering the same." This patent describes a method that produces exosomes capable of transferring active substances specifically to target tissues. The invention includes a pharmaceutical composition that uses these exosomes as active ingredients and details the preparation process of exosomes utilizing an expression vector that incorporates a target peptide.

Another significant contribution from Choi is a patent for "Compositions containing protein loaded exosome and methods for preparing and delivering the same." This invention relates to a mass-production method for exosomes containing a cargo protein. Choi's method ensures high yield production, enhancing the potential for these exosomes to be utilized effectively in disease treatment.

Career Highlights

Throughout his career, Chulhee Choi has been associated with reputable organizations such as Ilias Biologics Inc. and Korea Advanced Institute of Science and Technology (KAIST), where he has contributed to essential research that bridges innovation and clinical application. His work on exosomal technologies puts him at the forefront of advancements in targeted drug delivery.

Collaborations

In his journey, Chulhee Choi has collaborated with fellow researchers, including Kyungsun Choi and Nambin Yim. These partnerships have aided in the exchange of ideas and techniques that drive the field of biotechnology forward, underlining the importance of collaborative research in achieving significant scientific breakthroughs.

Conclusion

Chulhee Choi's dedication to innovation and his extensive work on exosome technology play a crucial role in the advancement of targeted therapies for various diseases. His patents reflect a commitment to improving the delivery of pharmaceutical agents, potentially transforming treatment paradigms in the medical field. As an inventor, Choi's contributions continue to influence both academic research and clinical practices, setting a benchmark for future innovations in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…